Page last updated: 2024-10-22

acetaminophen and Chronic Pain

acetaminophen has been researched along with Chronic Pain in 92 studies

Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.

Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.

Research Excerpts

ExcerptRelevanceReference
"Hydrocodone/acetaminophen combination analgesics are frequently prescribed for chronic pain management; however, acetaminophen presents potential hepatotoxicity to patients and thus dose limitations."9.20Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain. ( Bartoli, A; He, E; Michna, E; Wen, W, 2015)
"The goal of this study was to evaluate the efficacy and safety of extended-release tramadol hydrochloride 75-mg/acetaminophen 650-mg fixed-dose combination tablets (TA-ER) for the treatment of chronic low back pain."9.17A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain. ( Lee, CS; Lee, JH, 2013)
"The aim of the present study was to investigate the effect of perioperative administration of pregabalin on postoperative acute and chronic pain and analgesic requirements."9.16Perioperative pregabalin for acute and chronic pain after abdominal hysterectomy or myomectomy: a randomised controlled trial. ( Fassoulaki, A; Melemeni, A; Paraskeva, A; Tsaroucha, A, 2012)
"Ibuprofen and paracetamol have long been used as analgesics in a range of acute, intermittent and chronic pain conditions."8.91Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions. ( Aldington, DJ; Derry, S; Moore, RA; Straube, S; Wiffen, PJ, 2015)
" The patient was weaned from oxycodone ER 30 mg every 12 h and oxycodone/acetaminophen 10/325 mg 3x/day for breakthrough pain utilizing an unconventional approach."8.31Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report. ( Patel, KV; Sahni, S; Taylor, LF, 2023)
"Pregabalin in the context of multimodal pain management may be associated with reduced opioid consumption and other medical complications in patients undergoing TKA, including previous users of chronic pain medications."7.80Pregabalin reduces opioid consumption and improves outcome in chronic pain patients undergoing total knee arthroplasty. ( Chen, AF; Hozack, WJ; Parvizi, J; Sawan, H; Viscusi, ER, 2014)
"A total of 400 elderly patients with osteoarthritis of the hip and knee will be recruited from five institutions in Japan."7.30Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee. ( Aono, H; Endo, M; Hara, T; Kawahara, S; Kawano, T; Mawatari, T; Miyaji, T; Miyake, M; Nakashima, Y; Sakamoto, S; Sato, T; Shimokawa, M; Takano, T; Tokunaga, M; Zenda, S, 2023)
" IR/ER HB/APAP tablets deliver 25% of the HB dose and 50% of the APAP dose by IR and the remainder by ER over a 12-hour dosing interval."6.80Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain. ( Barrett, T; Chen, Y; Giuliani, MJ; Hisaw, E; Kostenbader, K; Young, JL; Zheng, Y, 2015)
" After cross-reference searches of both trials and 38 reviews, seven studies comparing acetaminophen in continuous dosing regimens of more than 2 weeks with placebo were included."6.53Acetaminophen for Chronic Pain: A Systematic Review on Efficacy. ( Dideriksen, D; Ennis, ZN; Handberg, G; Pottegård, A; Vaegter, HB, 2016)
"Acetaminophen's role in chronic pain conditions is understudied."5.56Attitudes toward and Barriers to Acetaminophen Use in the Chronic Pain Population: A Cross-Sectional Study. ( Foo, RMC; Hoff, C; Sekhri, NK; Weber, G, 2020)
"Tramadol-acetaminophen was effective at reducing chronic LBP and conferred a prophylactic motivational effect in patients with chronic LBP."5.43Effect of Tramadol/Acetaminophen on Motivation in Patients with Chronic Low Back Pain. ( Nishida, K; Ozaki, T; Takei, Y; Tanaka, M; Tetsunaga, T, 2016)
"Acetaminophen exposure was a time-dependent variable."5.42Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. ( Dawson, J; Dominiczak, AF; Fulton, RL; McInnes, GT; Meredith, PA; Morrison, DS; Morton, R; Padmanabhan, S; Touyz, RM; Walters, MR, 2015)
"Analgesic treatment did not reduce depression while placebo appeared to improve depressive symptoms significantly by comparison, possibly owing to the adverse effects of active buprenorphine."5.27Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM). ( Aarsland, D; Ballard, C; Erdal, A; Flo, E; Husebo, BS; Slettebo, DD, 2018)
"Anesthesia, acetaminophen, Persistent surgical pain, Postoperative acute pain."5.27Acetaminophen reduces acute and persistent incisional pain after hysterectomy. ( Akkurt, C; Hakimoglu, S; Koyuncu, O; Sessler, D; Turan, A; Turhanoglu, S; Ugur, M, 2018)
"Hydrocodone/acetaminophen combination analgesics are frequently prescribed for chronic pain management; however, acetaminophen presents potential hepatotoxicity to patients and thus dose limitations."5.20Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain. ( Bartoli, A; He, E; Michna, E; Wen, W, 2015)
"The goal of this study was to evaluate the efficacy and safety of extended-release tramadol hydrochloride 75-mg/acetaminophen 650-mg fixed-dose combination tablets (TA-ER) for the treatment of chronic low back pain."5.17A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain. ( Lee, CS; Lee, JH, 2013)
"The aim of the present study was to investigate the effect of perioperative administration of pregabalin on postoperative acute and chronic pain and analgesic requirements."5.16Perioperative pregabalin for acute and chronic pain after abdominal hysterectomy or myomectomy: a randomised controlled trial. ( Fassoulaki, A; Melemeni, A; Paraskeva, A; Tsaroucha, A, 2012)
" Paracetamol (acetaminophen; APAP) is the first intention treatment of chronic pain that is highly prevalent and persistent in the elderly."4.98Impact of medication on protein and amino acid metabolism in the elderly: the sulfur amino acid and paracetamol case. ( Dardevet, D; Mast, C; Papet, I, 2018)
"Paracetamol (acetaminophen) is the most commonly used drug in the world, with a long record of use in acute and chronic pain."4.98Long-term adverse effects of paracetamol - a review. ( Dear, JW; MacIntyre, IM; McCrae, JC; Morrison, EE; Webb, DJ, 2018)
" New evidence found that acetaminophen was ineffective for acute low back pain, nonsteroidal anti-inflammatory drugs had smaller benefits for chronic low back pain than previously observed, duloxetine was effective for chronic low back pain, and benzodiazepines were ineffective for radiculopathy."4.95Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. ( Chou, R; Dana, T; Deyo, R; Friedly, J; Fu, R; Griffin, J; Grusing, S; Kraegel, P; Skelly, A; Weimer, M, 2017)
"Ibuprofen and paracetamol have long been used as analgesics in a range of acute, intermittent and chronic pain conditions."4.91Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions. ( Aldington, DJ; Derry, S; Moore, RA; Straube, S; Wiffen, PJ, 2015)
" The patient was weaned from oxycodone ER 30 mg every 12 h and oxycodone/acetaminophen 10/325 mg 3x/day for breakthrough pain utilizing an unconventional approach."4.31Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report. ( Patel, KV; Sahni, S; Taylor, LF, 2023)
"Regression analysis showed that severe spinal cord injury and peri-treatment use of acetaminophen dihydrocodeine were both one of the risk factors for postoperative chronic pain."4.02A retrospective analysis of the effects of different analgesics on the pain of patients with traumatic thoracolumbar fractures in the peri-treatment period. ( Chang, QY; Chen, J; Gan, ZJ; Li, TT; Wang, YT; Wen, S; Xiong, LL; Yuan, H, 2021)
"Paracetamol (acetaminophen) is widely used for management of mild-to-moderate pain and reduction of fever."3.91Efficacy and safety of modified-release paracetamol for acute and chronic pain: a systematic review protocol. ( Dosenovic, S; Margan Koletic, Z; Puljak, L, 2019)
" In 1980 s, the relevance of aspirin for Reye's syndrome became a problem, then acetaminophen came into use for various kinds of cases such as children, pregnant women and the elderly for pain management or alleviation of fever."3.83[Side Effects of Acetaminophen and their Management]. ( Saeki, S, 2016)
"This study is aimed at examining the long-term effects of chronic pain during early life (postnatal day 0 to 8weeks), and intervention using sucrose, on cognitive functions during adulthood in rats."3.81Sucrose-induced analgesia during early life modulates adulthood learning and memory formation. ( Alabwaini, J; Alzoubi, KH; Kassab, MI; Khabour, OF; Nuseir, KQ, 2015)
"Pregabalin in the context of multimodal pain management may be associated with reduced opioid consumption and other medical complications in patients undergoing TKA, including previous users of chronic pain medications."3.80Pregabalin reduces opioid consumption and improves outcome in chronic pain patients undergoing total knee arthroplasty. ( Chen, AF; Hozack, WJ; Parvizi, J; Sawan, H; Viscusi, ER, 2014)
"A total of 400 elderly patients with osteoarthritis of the hip and knee will be recruited from five institutions in Japan."3.30Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee. ( Aono, H; Endo, M; Hara, T; Kawahara, S; Kawano, T; Mawatari, T; Miyaji, T; Miyake, M; Nakashima, Y; Sakamoto, S; Sato, T; Shimokawa, M; Takano, T; Tokunaga, M; Zenda, S, 2023)
"The study included 113 breast cancer patients after breast cancer surgery with axillary lymphadenectomy treated with either 75/650 mg or 37."3.30Association of ( Besic, N; Dolzan, V; Goricar, K; Strazisar, B; Vidic, Z, 2023)
"These exploratory results suggest that participation in N-of-1 trials may reduce long-term use of NSAIDs; there is also a weak signal for an effect on use of opioids."2.94Effect of Mobile Device-Assisted N-of-1 Trial Participation on Analgesic Prescribing for Chronic Pain: Randomized Controlled Trial. ( Cabrera, R; Duan, N; Henry, SG; Kravitz, RL; Marois, MT; Odineal, DD; Schmid, CH; Sim, I; Wang, Y; Ward, D; Wilsey, B, 2020)
"Chronic pain is associated with impaired regulation of cardiovascular and analgesia systems, which may predispose to persistent BP elevation."2.82The Effects of Pain and Analgesic Medications on Blood Pressure. ( Coscarelli, A; Giordano, A; Menale, S; Rivasi, G; Turrin, G; Ungar, A, 2022)
" IR/ER HB/APAP tablets deliver 25% of the HB dose and 50% of the APAP dose by IR and the remainder by ER over a 12-hour dosing interval."2.80Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain. ( Barrett, T; Chen, Y; Giuliani, MJ; Hisaw, E; Kostenbader, K; Young, JL; Zheng, Y, 2015)
"It is essential to find good postoperative pain control strategies that facilitate early mobility, early recovery, and early hospital discharge with minimal side effects on the mother and infant."2.66Strategies of analgesic treatment after cesarean delivery. Current state and new alternatives. ( Arroyo-Fernández, FJ; Calderón Seoane, JE; Torres Morera, LM, 2020)
" However, few data have been provided to clinicians about the pharmacokinetic drug-drug interactions of cannabinoids with other concomitant administered medications."2.66Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain. ( Guevara, N; Guido, PC; Maldonado, C; Schaiquevich, P; Vázquez, M, 2020)
"Acetaminophen has been commonly used as the fi rst-line treatment for OA pain and cLBP, but its long-term use is not recommended based on recent evidence."2.61Evidence-Based Recommendations on the Pharmacological Management of Osteoarthritis and Chronic Low Back Pain: An Asian Consensus ( Ip, AKK; Murakami, T; Shin, HK; Sun, WZ; Tam, CK; Ushida, T; Wang, JH; Williamson, OD; Yabuki, S, 2019)
"Chronic pain is a main symptom of many diseases in internal medicine."2.58[Errors and Solutions During Medical Therapy for Chronic Pain]. ( Häuser, W; Schuler, M, 2018)
" The recommended dosage in the UK, Europe, Australia, and the USA for children and adolescents is generally 10 to 15 mg/kg every four to six hours, with specific age ranges from 60 mg (6 to 12 months old) up to 500 to 1000 mg (over 12 years old)."2.55Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents. ( Anderson, B; Cooper, TE; Eccleston, C; Fisher, E; Wilkinson, NM; Williams, DG, 2017)
" After cross-reference searches of both trials and 38 reviews, seven studies comparing acetaminophen in continuous dosing regimens of more than 2 weeks with placebo were included."2.53Acetaminophen for Chronic Pain: A Systematic Review on Efficacy. ( Dideriksen, D; Ennis, ZN; Handberg, G; Pottegård, A; Vaegter, HB, 2016)
"For a woman with chronic pain, adequate use of pain killers during pregnancy is needed."2.53Ongoing Pharmacological Management of Chronic Pain in Pregnancy. ( Källén, B; Reis, M, 2016)
"Quality pain management for cancer survivors is complicated by the fact that cancer-related pain can be due to the tumor, surgery, radiation, and/or chemotherapy."2.50Understanding the cancer pain experience. ( Schreiber, JA, 2014)
"Appropriate treatment of pain requires an understanding of the characteristics of pain, including the severity and the nature of the pain-for example, acute versus chronic pain or nociceptive versus neuropathic pain."2.49An overview of pain management: the clinical efficacy and value of treatment. ( Nalamachu, S, 2013)
"Chronic pain is a debilitating condition that is associated with many common diseases; this places a major burden on the healthcare system."2.48Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. ( Cherubino, P; Fornasari, D; Labianca, R; Sarzi-Puttini, P; Vellucci, R; Zuccaro, SM, 2012)
"Postoperative chronic pain in spine surgery can be caused by damage or instability of spinal column; pressure on nerves or segment of spinal cord; or can be due to long lasting nociception caused by inflammation, infection or tumour."2.48[Chronic pain following spine surgery]. ( Derbent, A; Uyar, M; Yilmaz, B, 2012)
"In case of neuropathic pain, the benefit deriving from the use of a single active principle is relative."2.48[Skin ulcer pain]. ( Guerra, L; Pellicano, R, 2012)
"More than 1 billion people live with chronic pain, including 100 million Americans, with a majority utilizing prescription and over-the-counter (OTC) pain medications."1.91Perceptions of West Virginia Teens and Adults Regarding the Risks of Over-the-Counter Pain Medications. ( Garofoli, M; Hanif, A; Kuhn, S; Sraj, S, 2023)
"To investigate if chronic pain in children with cerebral palsy is undertreated with the current pharmacological/non-pharmacological interventions using a pain management index."1.91Presence and grade of undertreatment of pain in children with cerebral palsy. ( Sultan, T; Wong, C, 2023)
"Osteoarthritis (OA) is a chronic painful condition that often affects large joints such as the knee."1.91Analgesic utilization in people with knee osteoarthritis: A population-based study using primary care data. ( Gran, S; Knaggs, RD; Taqi, A, 2023)
"Most migraine guidelines now recommend paracetamol for mild to moderate pain."1.72Practice guidelines for the treatment of acute migraine and chronic knee osteoarthritis with paracetamol: an expert appraisal on evolution over time between scientific societies. ( Attal, N; Desmeules, J; Eschalier, A; Lanteri-Minet, M; Perrot, S, 2022)
" At the time of intervention, her opioid dosage was between 50-90 MME (Morphine milligram equivalent) (Norco 8 × 7."1.56Physician-Delivered Pain Neuroscience Education for Opioid Tapering: A Case Report. ( Agarwal, V; Louw, A; Puentedura, EJ, 2020)
"Acetaminophen's role in chronic pain conditions is understudied."1.56Attitudes toward and Barriers to Acetaminophen Use in the Chronic Pain Population: A Cross-Sectional Study. ( Foo, RMC; Hoff, C; Sekhri, NK; Weber, G, 2020)
"Acute pain was associated with a variety of surgical procedures and patients were examined before and after surgical procedures."1.48The glycation products before and after therapy for acute and chronic pain. ( Fricová, J; Holeček, V; Houdek, K; Lejčko, J; Nedvídek, J; Rokyta, R; Trefil, L, 2018)
"GR consumption improved mechanical and thermal allodynia and mechanical hyperalgesia and improved behavioural changes related to cognitive disturbances, anxiety, and depression."1.48Ginger rhizome enhances the anti-inflammatory and anti-nociceptive effects of paracetamol in an experimental mouse model of fibromyalgia. ( De la Puerta, R; Fernandez-Arche, A; Garcia-Gimenez, MD; Montserrat-de la Paz, S; Quilez, AM, 2018)
" Suggested dosing regimens are proposed."1.46Oral Multimodal Analgesia for Total Joint Arthroplasty. ( Balch, KR; Dalury, DF; Golladay, GJ; Jiranek, WA; Satpathy, J, 2017)
"We studied 599 participants who reported chronic pain at baseline."1.46Pain severity and pharmacologic pain management among community-living older adults: the MOBILIZE Boston study. ( Bean, JF; Leveille, SG; Nawai, A; Shmerling, RH; van der Leeuw, G, 2017)
"However, elderly people with chronic pain rarely used the medications specifically for neuropathic pain."1.43Chronic pain among community-dwelling elderly: a population-based clinical study. ( Haanpää, M; Liira, H; Rapo-Pylkkö, S, 2016)
"Tramadol-acetaminophen was effective at reducing chronic LBP and conferred a prophylactic motivational effect in patients with chronic LBP."1.43Effect of Tramadol/Acetaminophen on Motivation in Patients with Chronic Low Back Pain. ( Nishida, K; Ozaki, T; Takei, Y; Tanaka, M; Tetsunaga, T, 2016)
" Collected data included socio-demographics, treatment information, incidence of adverse drug reactions (ADRs), numerical rating scale for intensity of pain, EuroQol-5D (EQ-5D) scale, and physician's global impression (PGI) during the 12 week observation period."1.42Overall safety profile and effectiveness of tramadol hydrochloride/acetaminophen in patients with chronic noncancer pain in Japanese real-world practice. ( Fujie, M; Kawai, K; Ogawa, Y; Suzuki, J; Yajima, T; Yokomori, J; Yoshizawa, K, 2015)
"Acetaminophen exposure was a time-dependent variable."1.42Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. ( Dawson, J; Dominiczak, AF; Fulton, RL; McInnes, GT; Meredith, PA; Morrison, DS; Morton, R; Padmanabhan, S; Touyz, RM; Walters, MR, 2015)
"Among subjects reporting chronic pain the prevalence of OTC analgesic use was almost twice as high as among subjects without chronic pain."1.42Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids. ( Borchgrevink, PC; Dale, O; Fredheim, OM; Mahic, M; Romundstad, P; Skurtveit, S, 2015)
"The target population was HIV and AIDS patients who had been using the primary health clinic for chronic pain management."1.39The management of HIV- and AIDS-related pain in a primary health clinic in Tshwane, South Africa. ( Dreyer Wright, SC; Makua, MR; Maree, JE, 2013)

Research

Studies (92)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's73 (79.35)24.3611
2020's19 (20.65)2.80

Authors

AuthorsStudies
Perrot, S1
Eschalier, A1
Desmeules, J1
Lanteri-Minet, M1
Attal, N1
Rivasi, G1
Menale, S1
Turrin, G1
Coscarelli, A1
Giordano, A1
Ungar, A1
Patel, KV1
Sahni, S1
Taylor, LF1
Endo, M1
Kawahara, S1
Sato, T1
Tokunaga, M1
Hara, T1
Mawatari, T1
Kawano, T1
Zenda, S1
Miyaji, T1
Shimokawa, M1
Sakamoto, S1
Takano, T1
Miyake, M1
Aono, H1
Nakashima, Y1
Taqi, A1
Gran, S1
Knaggs, RD1
Garofoli, M1
Hanif, A1
Sraj, S1
Kuhn, S1
Vidic, Z1
Goricar, K1
Strazisar, B1
Besic, N1
Dolzan, V1
Sultan, T1
Wong, C1
Jin, L1
Liang, Y1
Yu, Y1
Miao, P1
Huang, Y1
Xu, L1
Wang, H1
Wang, C1
Huang, J1
Guo, K1
Odineal, DD1
Marois, MT1
Ward, D1
Schmid, CH1
Cabrera, R1
Sim, I1
Wang, Y1
Wilsey, B1
Duan, N1
Henry, SG1
Kravitz, RL1
Stevens, J1
Bhalla, T1
Margan Koletic, Z1
Dosenovic, S1
Puljak, L2
Arroyo-Fernández, FJ1
Calderón Seoane, JE1
Torres Morera, LM1
Foo, RMC1
Hoff, C1
Sekhri, NK1
Weber, G1
Dhokia, M1
Elander, J1
Clements, K1
Gilbert, P1
Agarwal, V1
Louw, A1
Puentedura, EJ1
Ide, K1
Fujiwara, T1
Shimada, N1
Tokumasu, H1
Vázquez, M1
Guevara, N1
Maldonado, C1
Guido, PC1
Schaiquevich, P1
Koes, B1
Schreijenberg, M1
Tkachev, A1
Migliorini, F1
Maffulli, N1
Eschweiler, J1
Betsch, M1
Catalano, G1
Driessen, A1
Tingart, M1
Baroncini, A1
Yuan, H1
Chang, QY1
Chen, J1
Wang, YT1
Gan, ZJ1
Wen, S1
Li, TT1
Xiong, LL1
Golladay, GJ1
Balch, KR1
Dalury, DF1
Satpathy, J1
Jiranek, WA1
Cooper, TE1
Fisher, E1
Anderson, B1
Wilkinson, NM1
Williams, DG1
Eccleston, C1
Montserrat-de la Paz, S1
Garcia-Gimenez, MD1
Quilez, AM1
De la Puerta, R1
Fernandez-Arche, A1
Visconti, A1
Krebs, EE1
Gravely, A1
Nugent, S1
Jensen, AC1
DeRonne, B1
Goldsmith, ES1
Kroenke, K1
Bair, MJ1
Noorbaloochi, S1
Mast, C1
Dardevet, D1
Papet, I1
Benitez-Camps, M1
Morros Padrós, R1
Pera-Pujadas, H1
Dalfó Baqué, A1
Bayó Llibre, J1
Rebagliato Nadal, O1
Cortès Martinez, J1
García Sangenís, A1
Roca Saumell, C1
Coll de Tuero, G1
Vinyoles-Bargalló, E1
Kaye, AD1
Cornett, EM1
Hart, B1
Patil, S1
Pham, A1
Spalitta, M1
Mancuso, KF1
Vellucci, R2
Terenzi, R1
Kanis, JA1
Kress, HG1
Mediati, RD1
Reginster, JY1
Rizzoli, R1
Brandi, ML1
Erdal, A1
Flo, E1
Aarsland, D1
Ballard, C1
Slettebo, DD1
Husebo, BS1
McCrae, JC1
Morrison, EE1
MacIntyre, IM1
Dear, JW1
Webb, DJ1
Häuser, W1
Schuler, M1
Koyuncu, O1
Hakimoglu, S1
Ugur, M1
Akkurt, C1
Turhanoglu, S1
Sessler, D1
Turan, A1
Saeki, S1
Rokyta, R1
Lejčko, J1
Houdek, K1
Trefil, L1
Nedvídek, J1
Fricová, J1
Holeček, V1
Abualnadi, N1
Dizon, AM1
Schiff, L1
Radman, M1
Babic, A1
Runjic, E1
Jelicic Kadic, A1
Jeric, M1
Moja, L1
Davison, SN1
Yabuki, S1
Ip, AKK1
Tam, CK1
Murakami, T1
Ushida, T1
Wang, JH1
Shin, HK1
Sun, WZ1
Williamson, OD1
Robinson, PJ1
Rickard, JA1
Maree, JE1
Dreyer Wright, SC1
Makua, MR1
Yokotsuka, S1
Kato, J1
Meyer, CR1
Farquhar-Smith, P1
Gubbay, A1
Bertin, P1
Becquemont, L1
Corruble, E1
Derumeaux, G1
Falissard, B1
Hanon, O1
Pinget, M1
Forette, F1
Lee, JH1
Lee, CS1
Giese, A1
Ornek, A1
Kurucay, M1
Kilic, L1
Şendur, SN1
Münker, A1
Puchstein, C1
Lainka, E1
Wittkowski, H1
Henning, BF1
Richette, P1
McCartney, CJ1
Nelligan, K1
Nalamachu, S1
Schiphorst Preuper, HR1
Geertzen, JH1
van Wijhe, M1
Boonstra, AM1
Molmans, BH1
Dijkstra, PU1
Reneman, MF1
Meeus, M1
Hermans, L1
Ickmans, K1
Struyf, F1
Van Cauwenbergh, D1
Bronckaerts, L1
De Clerck, LS1
Moorken, G1
Hans, G1
Grosemans, S1
Nijs, J1
Cosio, D1
Sawan, H1
Chen, AF1
Viscusi, ER1
Parvizi, J1
Hozack, WJ1
Schreiber, JA1
Fassoulaki, A2
Chassiakos, D1
Melemeni, A2
Hard, B1
Bartoli, A1
Michna, E1
He, E1
Wen, W1
Moore, RA2
Derry, S2
Wiffen, PJ2
Straube, S1
Aldington, DJ1
Malec, M1
Shega, JW1
Fulton, RL1
Walters, MR1
Morton, R1
Touyz, RM1
Dominiczak, AF1
Morrison, DS1
Padmanabhan, S1
Meredith, PA1
McInnes, GT1
Dawson, J1
Glasser, SP1
Khodneva, Y1
Nuseir, KQ1
Alzoubi, KH1
Alabwaini, J1
Khabour, OF1
Kassab, MI1
Kurita Varoli, F1
Sucena Pita, M1
Sato, S1
Issa, JP1
do Nascimento, C1
Pedrazzi, V1
Zheng, Y1
Kostenbader, K1
Barrett, T2
Hisaw, E1
Giuliani, MJ1
Chen, Y1
Young, JL2
Dale, O1
Borchgrevink, PC1
Fredheim, OM1
Mahic, M1
Romundstad, P1
Skurtveit, S1
Eisenhauer, TD1
Matchett, M1
Heasley, R1
Morton, T1
Devarakonda, K1
Giuliani, M1
Hoban, B1
Larance, B1
Gisev, N1
Nielsen, S1
Cohen, M1
Bruno, R1
Shand, F1
Lintzeris, N1
Hall, W1
Farrell, M1
Degenhardt, L1
Nielsen, RV1
Siegel, H1
Fomsgaard, JS1
Andersen, JDH1
Martusevicius, R1
Mathiesen, O1
Dahl, JB1
Yoshizawa, K1
Kawai, K1
Fujie, M1
Suzuki, J1
Ogawa, Y1
Yajima, T1
Yokomori, J1
Ennis, ZN1
Dideriksen, D1
Vaegter, HB1
Handberg, G1
Pottegård, A1
Bugada, D1
Lavand'homme, P1
Ambrosoli, AL1
Cappelleri, G1
Saccani Jotti, GM1
Meschi, T1
Fanelli, G1
Allegri, M1
Rapo-Pylkkö, S1
Haanpää, M1
Liira, H1
Lawrence, R1
Källén, B1
Reis, M1
Motov, SM1
Nelson, LS1
Mo, L1
Liang, D1
Madden, A1
Aung, AK1
Tetsunaga, T2
Tanaka, M1
Nishida, K1
Takei, Y1
Ozaki, T1
Hultzsch, S1
Schaefer, C1
Knaggs, R1
Cole, P1
Phillips, T1
Chou, R1
Deyo, R1
Friedly, J1
Skelly, A1
Weimer, M1
Fu, R1
Dana, T1
Kraegel, P1
Griffin, J1
Grusing, S1
Nawai, A1
Leveille, SG1
Shmerling, RH1
van der Leeuw, G1
Bean, JF1
Kesiktas, N1
Karakas, S1
Gun, K1
Gun, N1
Murat, S1
Uludag, M1
O'Connor, ES1
Schwarze, ML1
Kodner, IJ1
Keune, JD1
Du, Y1
Ellert, U1
Zhuang, W1
Knopf, H1
Derbent, A1
Yilmaz, B1
Uyar, M1
Woitzek, K1
Park, SC1
Kim, KH1
Tsaroucha, A1
Paraskeva, A1
Pellicano, R1
Guerra, L1
Labianca, R1
Sarzi-Puttini, P1
Zuccaro, SM1
Cherubino, P1
Fornasari, D1

Clinical Trials (24)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
N-of-1 Trials Using mHealth in Chronic Pain Aka PREEMPT (Personalized Research for Monitoring Pain Treatment)[NCT02116621]215 participants (Actual)Interventional2014-07-31Completed
Efficacy of Different Doses of Pregabalin as a Multimodal Analgesic Agent in Postoperative Pain Control After Total Knee Arthroplasty - A Randomized Controlled Trial[NCT05447364]Phase 482 participants (Anticipated)Interventional2021-07-01Recruiting
Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room[NCT04811521]375 participants (Anticipated)Interventional2021-04-01Enrolling by invitation
Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) Trial[NCT01583985]265 participants (Actual)Interventional2013-06-01Completed
Video-based, Patient-Focused Opioid Education in the Perioperative Period: A Feasibility Study[NCT03986866]110 participants (Actual)Interventional2019-04-29Completed
Achieving Peri-Operative Pain Control Without Opioids[NCT04813991]Phase 30 participants (Actual)Interventional2022-03-15Withdrawn (stopped due to Enrollment was never initiated and the PI is leaving the institution so the study is closing.)
Efficacy of Pain Treatment on Depression in Patients With Dementia. A Randomized Clinical Trial.[NCT02267057]Phase 4163 participants (Actual)Interventional2014-08-31Completed
National Observatory on the Therapeutic Management in Ambulatory Care Patients Aged 65 and Over, With Diabetes Type 2, Chronic Pain or Atrial Fibrillation[NCT01065909]3,491 participants (Actual)Observational2009-05-31Completed
A Randomized, Placebo-Controlled, Parallel Group, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Tramadol HCl/Acetaminophen Extended Release Tablet in Subjects With Chronic Low Back Pain[NCT01112267]Phase 3248 participants (Actual)Interventional2009-05-31Completed
Opioid-Free Shoulder Arthroplasty[NCT03540030]Phase 486 participants (Actual)Interventional2016-09-30Completed
Efficacy and Side Effects of Intrathecal Morphine in Multimodal Analgesia for Unilateral Total Knee Arthroplasty[NCT03232957]131 participants (Actual)Interventional2017-08-01Completed
Effect of Paracetamol and Ibuprofen When Intravenously Given Combination or Alone in Reducing Morphine Requirements After Total Knee Arthroplasty[NCT04414995]Phase 2/Phase 336 participants (Actual)Interventional2020-06-05Completed
Evaluating Change in Back Pain From Access to a Sit-stand Workstation[NCT02146482]57 participants (Actual)Interventional2013-04-30Completed
Unraveling Impaired Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes: a Series of Experiments Targeting Brain Neurotransmission[NCT01154647]70 participants (Anticipated)Interventional2010-09-30Not yet recruiting
Hypoalgesic Effect of Median Nerve Neural Mobilization in Cervicobrachial Pain Compared to a Controlled Group[NCT02596815]51 participants (Actual)Interventional2015-07-31Completed
Hypoalgesic Effect of Neural Mobilization in Cervicobrachial Pain Compared to a Controlled Group[NCT02595294]52 participants (Actual)Interventional2015-07-31Completed
Hypoalgesic Effect of Median Nerve Neural Mobilization Versus Ibuprofen Pharmacologic Treatment in Patients With Cervicobrachial Pain[NCT02593721]Phase 2/Phase 350 participants (Actual)Interventional2015-07-31Completed
Randomized Double-blind Controlled Study to Assess the Efficacy of Intravenous Acetaminophen Associated With Strong Opioids in the Management of Acute Pain in Adult Cancer Patients[NCT04779567]Phase 4112 participants (Actual)Interventional2019-06-10Completed
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain[NCT01722864]Phase 3153 participants (Actual)Interventional2012-11-30Completed
The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen as Adjuvant, Postoperative Pain After Herniated Disc Surgery[NCT01953978]Phase 4160 participants (Actual)Interventional2012-12-31Completed
A Combination Study With Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain in the Emergency Department[NCT03959852]Phase 46 participants (Actual)Interventional2019-11-18Terminated (stopped due to Residency completed.)
Trigger Point Injection for Myofascial Pain Syndrome in the Low Back (T-PIMPS): A Randomized Controlled Trial.[NCT04704297]Phase 4180 participants (Anticipated)Interventional2020-12-28Recruiting
Electroacupuncture Frequency-related Effects on Chronic Low Back Pain in Older Adults: Triple-blind, 12-month Protocol for a Randomized Controlled Trial.[NCT03802045]125 participants (Anticipated)Interventional2019-05-01Recruiting
Determining the Effectiveness of the Geriatric Pain Measure ın Older Adults Attending a Gynecology Clinic[NCT04789590]100 participants (Actual)Observational2018-08-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change From Baseline in Analgesic Adherence (Overuse) on the Pain Medication in Primary Care Patient Questionnaire at 13 Weeks

Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications at baseline and 13 weeks. Two questions comprised a subscale assessing overuse of medications. Overuse scores range from 0 - 100. Higher scores indicate greater adherence and less overuse of medications. Data table measures show change over time with positive numbers indicating greater adherence (less overuse of medications) and negative numbers indicating less adherence. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention1.40
Control-Usual Care0.35

Change From Baseline in Analgesic Adherence (Overuse) on the Pain Medication in Primary Care Patient Questionnaire at 26 Weeks

Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications at baseline and 26 weeks. Two questions comprised a subscale assessing overuse of medications. Overuse scores range from 0 - 100. Higher scores indicate greater adherence and less overuse of medications. Data table measures show change over time with positive numbers indicating greater adherence (less overuse of medications) and negative numbers indicating less adherence. (NCT02116621)
Timeframe: Baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention1.77
Control-Usual Care-0.13

Change From Baseline in Analgesic Adherence (Overuse) on the Pain Medication in Primary Care Patient Questionnaire at 52 Weeks

Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications at baseline and 52 weeks. Two questions comprised a subscale assessing overuse of medications. Overuse scores range from 0 - 100. Higher scores indicate greater adherence and less overuse of medications. Data table measures show change over time with positive numbers indicating greater adherence (less overuse of medications) and negative numbers indicating less adherence. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention1.61
Control-Usual Care1.53

Change From Baseline in Analgesic Adherence (Underuse) on the Pain Medication in Primary Care Patient Questionnaire at 13 Weeks

Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications at baseline and 13 weeks. Two questions comprised a subscale assessing underuse of medications. Underuse scores range from 0-100. Higher scores indicate greater adherence and less underuse of medication. Data table measures show change over time with positive numbers indicating greater adherence (less underuse of medications) and negative numbers indicating less adherence. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention2.53
Control-Usual Care-1.71

Change From Baseline in Analgesic Adherence (Underuse) on the Pain Medication in Primary Care Patient Questionnaire at 26 Weeks

Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications at baseline and 26 weeks. Two questions comprised a subscale assessing underuse of medications. Underuse scores range from 0-100. Higher scores indicate greater adherence and less underuse of medication. Data table measures show change over time with positive numbers indicating greater adherence (less underuse of medications) and negative numbers indicating less adherence. (NCT02116621)
Timeframe: Baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention1.88
Control-Usual Care-2.76

Change From Baseline in Analgesic Adherence (Underuse) on the Pain Medication in Primary Care Patient Questionnaire at 52 Weeks

Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications at baseline and 52 weeks. Two questions comprised a subscale assessing underuse of medications. Underuse scores range from 0-100. Higher scores indicate greater adherence and less underuse of medication. Data table measures show change over time with positive numbers indicating greater adherence (less underuse of medications) and negative numbers indicating less adherence. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-3.53
Control-Usual Care-1.62

Change From Baseline in Pain Intensity on the Patient-Reported Outcomes Measurement Information System (PROMIS) Scale at 13 Weeks

Pain intensity measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 3a short form at baseline and 13 weeks, which measures self-reported estimate of how much a person hurts. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain intensity scores range from 0 - 100. For pain intensity, higher scores indicate greater pain intensity. Data table measures show change over time with negative numbers indicating improvement (decreases) and positive numbers indicating increases in pain intensity. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-1.60
Control-Usual Care-1.92

Change From Baseline in Pain Intensity on the Patient-Reported Outcomes Measurement Information System (PROMIS) Scale at 26 Weeks

Pain intensity measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 3a short form at baseline and 26 weeks, which measures self-reported estimate of how much a person hurts. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain intensity scores range from 0 - 100. For pain intensity, higher scores indicate greater pain intensity. Data table measures show change over time with negative numbers indicating improvement (decreases) and positive numbers indicating increases in pain intensity. (NCT02116621)
Timeframe: Baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-2.86
Control-Usual Care-1.46

Change From Baseline in Pain Intensity on the Patient-Reported Outcomes Measurement Information System (PROMIS) Scale at 52 Weeks

Pain intensity measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 3a short form at baseline and 52 weeks, which measures self-reported estimate of how much a person hurts. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain intensity scores range from 0 - 100. For pain intensity, higher scores indicate greater pain intensity. Data table measures show change over time with negative numbers indicating improvement (decreases) and positive numbers indicating increases in pain intensity. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-3.00
Control-Usual Care-1.76

Change From Baseline in Pain-related Interference on the Patient Reported Outcomes Measurement Information System (PROMIS) Scale at 26 Weeks

Pain interference measured with Patient Reported Outcomes Measurement Information System (PROMIS) Scale 8-item short form at baseline and 26 weeks which measures self-reported consequences of pain on relevant aspects of one's life. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain interference scores range from 0 - 100. For pain interference, higher scores indicate greater pain interference. Data table measures show change over time with negative numbers indicating improvement (decreases) and positive numbers indicating increases in pain interference. (NCT02116621)
Timeframe: baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-3.22
Control-Usual Care-1.85

Change From Baseline in Pain-related Interference on the Patient-Reported Outcomes Measurement Information System (PROMIS) Scale at 13 Weeks

Pain-related interference measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 8-item short form at baseline and 13 weeks which measures self-reported consequences of pain on relevant aspects of one's life. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain interference scores range from 0 - 100. For pain interference, higher scores indicate greater pain interference. Data table measures show change over time with negative numbers indicating improvement (decreases) and positive numbers indicating increases in pain interference. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-2.70
Control-Usual Care-1.91

Change From Baseline in Pain-related Interference on the Patient-Reported Outcomes Measurement Information System (PROMIS) Scale at 52 Weeks

Pain-related interference measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 8-item short form at baseline and 52 weeks which measures self-reported consequences of pain on relevant aspects of one's life. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain interference scores range from 0 - 100. For pain interference, higher scores indicate greater pain interference. Data table measures show change over time with negative numbers indicating improvement (decreases) and positive numbers indicating increases in pain interference. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-2.67
Control-Usual Care-2.83

Change From Baseline in Participatory Decision-making on the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Surveys at 26 Weeks

Four questions from the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey assessed patient-provider discussions on starting/stopping medications and comprise medication related shared decision making. Scores were computed only for patients who reported discussing medications with their clinician in the past 12 months. Medication related shared decision making scores range from 0-100. Higher scores indicate more shared decision making. (NCT02116621)
Timeframe: 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention79.6
Control-Usual Care67.7

Change From Baseline in Participatory Decision-making on the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Surveys at 52 Weeks

Four questions from the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey assessed patient-provider discussions on starting/stopping medications and comprise medication related shared decision making. Scores were computed only for patients who reported discussing medications with their clinician in the past 12 months. Medication related shared decision making scores range from 0-100. Higher scores indicate more shared decision making. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention74.8
Control-Usual Care65.4

Change From Baseline in Patient-provider Relationship on the Trust in Physician Scale at 13 Weeks

Patient trust in physician measured with 11-item Trust in Physician Scale at baseline and 13 weeks to assess the quality of the patient-clinician relationship. Trust in physician scores range from 0 - 100. Higher scores indicate greater patient trust in the clinician providing pain treatment. Data table measures show change over time with positive numbers indicating increases in trust and negative numbers indicating declines in trust. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-2.49
Control-Usual Care-4.25

Change From Baseline in Patient-provider Relationship on the Trust in Physician Scale at 26 Weeks

Patient trust in physician measured with 11-item Trust in Physician Scale at baseline and 26 weeks to assess the quality of the patient-clinician relationship. Trust in physician scores range from 0 - 100. Higher scores indicate greater patient trust in the clinician providing pain treatment. Data table measures show change over time with positive numbers indicating increases in trust and negative numbers indicating declines in trust. (NCT02116621)
Timeframe: Baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-2.30
Control-Usual Care-4.84

Change From Baseline in Patient-provider Relationship on the Trust in Physician Scale at 52 Weeks

Patient trust in physician measured with 11-item Trust in Physician Scale at baseline and 52 weeks to assess the quality of the patient-clinician relationship. Trust in physician scores range from 0 - 100. Higher scores indicate greater patient trust in the clinician providing pain treatment. Data table measures show change over time with positive numbers indicating increases in trust and negative numbers indicating declines in trust. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-4.00
Control-Usual Care-5.53

Change From Baseline on the Pain Treatment Satisfaction Scale (PTSS) - Satisfaction With Medical Care at 13 Weeks

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline and 13 weeks, creating three subscales. Satisfaction with medical care is a subscale that includes 5 questions assessing medical care for pain. Satisfaction with medical care scores range from 0 - 100. Higher scores indicate greater patient satisfaction with medical care. Data table measures show change over time with positive numbers indicating increases in satisfaction with medical care and negative numbers indicating declines in patient satisfaction. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-4.00
Control-Usual Care-6.15

Change From Baseline on the Pain Treatment Satisfaction Scale (PTSS) - Satisfaction With Medical Care at 26 Weeks

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline and 26 weeks, creating three subscales. Satisfaction with medical care is a subscale that includes 5 questions assessing medical care for pain. Satisfaction with medical care scores range from 0 - 100. Higher scores indicate greater patient satisfaction with medical care. Data table measures show change over time with positive numbers indicating increases in satisfaction with medical care and negative numbers indicating declines in patient satisfaction. (NCT02116621)
Timeframe: Baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-2.26
Control-Usual Care-5.57

Change From Baseline on the Pain Treatment Satisfaction Scale (PTSS) - Satisfaction With Medical Care at 52 Weeks

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline and 52 weeks, creating three subscales. Satisfaction with medical care is a subscale that includes 5 questions assessing medical care for pain. Satisfaction with medical care scores range from 0 - 100. Higher scores indicate greater patient satisfaction with medical care. Data table measures show change over time with positive numbers indicating increases in satisfaction with medical care and negative numbers indicating declines in patient satisfaction. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-4.52
Control-Usual Care-5.51

Change From Baseline on the Pain Treatment Satisfaction Scale (PTSS) - Satisfaction With Pain Information at 13 Weeks

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline and 13 weeks, creating three subscales. Satisfaction with pain information is a subscale that includes 5 questions assessing information about pain and its treatment. Satisfaction with pain information range from 0-100. Higher scores indicate greater patient satisfaction with information received about pain and treatment for pain. Data table measures show change over time with positive numbers indicating increases in satisfaction with pain information and negative numbers indicating declines in patient satisfaction. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention4.41
Control-Usual Care-3.36

Change From Baseline on the Pain Treatment Satisfaction Scale (PTSS) - Satisfaction With Pain Information at 26 Weeks

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline and 26 weeks, creating three subscales. Satisfaction with pain information is a subscale that includes 5 questions assessing information about pain and its treatment. Satisfaction with pain information range from 0-100. Higher scores indicate greater patient satisfaction with information received about pain and treatment for pain. Data table measures show change over time with positive numbers indicating increases in satisfaction with pain information and negative numbers indicating declines in patient satisfaction. (NCT02116621)
Timeframe: Baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention11.28
Control-Usual Care3.99

Change From Baseline on the Pain Treatment Satisfaction Scale (PTSS) - Satisfaction With Pain Information at 52 Weeks

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline and 52 weeks, creating three subscales. Satisfaction with pain information is a subscale that includes 5 questions assessing information about pain and its treatment. Satisfaction with pain information range from 0-100. Higher scores indicate greater patient satisfaction with information received about pain and treatment for pain. Data table measures show change over time with positive numbers indicating increases in satisfaction with pain information and negative numbers indicating declines in patient satisfaction. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention9.02
Control-Usual Care4.89

Change From Baseline on the Pain Treatment Satisfaction Scale (PTSS) - Satisfaction With Pain Medication at 13 Weeks

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline and 13 weeks, creating three subscales. Satisfaction with current pain medication is a subscale that includes 8 questions assessing current pain medications. Satisfaction with pain medication scores range from 0-100. Higher scores indicate greater patient satisfaction with current pain medications. Data table measures show change over time with positive numbers indicating increases in satisfaction with pain medications and negative numbers indicating declines in satisfaction with pain medications. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention1.46
Control-Usual Care-0.34

Change From Baseline on the Pain Treatment Satisfaction Scale (PTSS) - Satisfaction With Pain Medication at 26 Weeks

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline and 26 weeks, creating three subscales. Satisfaction with current pain medication is a subscale that includes 8 questions assessing current pain medications. Satisfaction with pain medication scores range from 0-100. Higher scores indicate greater patient satisfaction with current pain medications. Data table measures show change over time with positive numbers indicating increases in satisfaction with pain medications and negative numbers indicating declines in satisfaction with pain medications. (NCT02116621)
Timeframe: Baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-0.18
Control-Usual Care1.39

Change From Baseline on the Pain Treatment Satisfaction Scale (PTSS) - Satisfaction With Pain Medication at 52 Weeks

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline and 52 weeks, creating three subscales. Satisfaction with current pain medication is a subscale that includes 8 questions assessing current pain medications. Satisfaction with pain medication scores range from 0-100. Higher scores indicate greater patient satisfaction with current pain medications. Data table measures show change over time with positive numbers indicating increases in satisfaction with pain medications and negative numbers indicating declines in satisfaction with pain medications. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention0.77
Control-Usual Care-0.34

Change From Baseline on the Patient-Reported Outcomes Measurement Information System (PROMIS) MENTAL Global Health Scale at 13 Weeks

Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale at baseline and 13 weeks, representing physical and mental health components. Global mental health measures mental health, quality of life, satisfaction with social activities and emotional problems. The final mental health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Global mental health scores range from 0 - 100, and higher scores indicate better mental health. Data table measures show change over time with positive numbers indicating improvement in global mental health and negative numbers indicating declines in global mental health. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention-0.35
Control-Usual Care0.30

Change From Baseline on the Patient-Reported Outcomes Measurement Information System (PROMIS) MENTAL Global Health Scale at 26 Weeks

Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale at baseline and 26 weeks, representing physical and mental health components. Global mental health measures mental health, quality of life, satisfaction with social activities and emotional problems. The final mental health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Global mental health scores range from 0 - 100, and higher scores indicate better mental health. Data table measures show change over time with positive numbers indicating improvement in global mental health and negative numbers indicating declines in global mental health. (NCT02116621)
Timeframe: Baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention0.21
Control-Usual Care-0.72

Change From Baseline on the Patient-Reported Outcomes Measurement Information System (PROMIS) MENTAL Global Health Scale at 52 Weeks

Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale at baseline and 52 weeks, representing physical and mental health components. Global mental health measures mental health, quality of life, satisfaction with social activities and emotional problems. The final mental health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Global mental health scores range from 0 - 100, and higher scores indicate better mental health. Data table measures show change over time with positive numbers indicating improvement in global mental health and negative numbers indicating declines in global mental health. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention0.36
Control-Usual Care-0.39

Change From Baseline on the Patient-Reported Outcomes Measurement Information System (PROMIS) PHYSICAL Global Health Scale at 13 Weeks

Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale at baseline and 13 weeks, representing physical and mental health components. Global physical health measures overall physical health, physical function, pain and fatigue. The final physical health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Physical global health scores range from 0 - 100, and higher scores indicate better physical health. Data table measures show change over time with positive numbers indicating improvement in global physical health and negative numbers indicating declines in global physical health. (NCT02116621)
Timeframe: Baseline, 13 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention0.73
Control-Usual Care0.44

Change From Baseline on the Patient-Reported Outcomes Measurement Information System (PROMIS) PHYSICAL Global Health Scale at 26 Weeks

Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale at baseline and 26 weeks, representing physical and mental health components. Global physical health measures overall physical health, physical function, pain and fatigue. The final physical health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Physical global health scores range from 0 - 100, and higher scores indicate better physical health. Data table measures show change over time with positive numbers indicating improvement in global physical health and negative numbers indicating declines in global physical health. (NCT02116621)
Timeframe: Baseline, 26 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention0.13
Control-Usual Care0.30

Change From Baseline on the Patient-Reported Outcomes Measurement Information System (PROMIS) PHYSICAL Global Health Scale at 52 Weeks

Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale at baseline and 52 weeks, representing physical and mental health components. Global physical health measures overall physical health, physical function, pain and fatigue. The final physical health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Physical global health scores range from 0 - 100, and higher scores indicate better physical health. Data table measures show change over time with positive numbers indicating improvement in global physical health and negative numbers indicating declines in global physical health. (NCT02116621)
Timeframe: Baseline, 52 weeks

Interventionunits on a scale (Least Squares Mean)
Trialist Intervention0.16
Control-Usual Care0.42

Longitudinal Change From Baseline up to 52 Weeks Follow-up in Analgesic Adherence (Overuse) on the Pain Medication in Primary Care Patient Questionnaire

Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications at baseline, 13 weeks, 26 weeks, 52 weeks. Two questions comprised a subscale assessing overuse of medications. Overuse scores range from 0 - 100. Higher scores indicate greater adherence and less overuse of medications. Data table measures show change over time with positive numbers indicating greater adherence (less overuse of medications) and negative numbers indicating less adherence. (NCT02116621)
Timeframe: Baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care0.35-0.131.53
Trialist Intervention1.401.771.61

Longitudinal Change From Baseline up to 52 Weeks Follow-up in Analgesic Adherence (Underuse) on the Pain Medication in Primary Care Patient Questionnaire

Four questions from the Pain Medication in Primary Care Patient Questionnaire measured adherence to medications at baseline, 13 weeks, 26 weeks, 52 weeks. Two questions comprised a subscale assessing underuse of medications. Underuse scores range from 0-100. Higher scores indicate greater adherence and less underuse of medication. Data table measures show change over time with positive numbers indicating greater adherence (less underuse of medications) and negative numbers indicating less adherence. (NCT02116621)
Timeframe: baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care-1.71-2.76-1.62
Trialist Intervention2.531.88-3.53

Longitudinal Change From Baseline up to 52 Weeks Follow-up in Pain Intensity on the Patient-Reported Outcomes Measurement Information System (PROMIS) Scale

Pain intensity measured with Patient-Reported Outcomes Measurement Information System (PROMIS) 3a short form at baseline, 13 weeks, 26 weeks, and 52 weeks which measures self-reported estimate of how much a person hurts. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain intensity scores range from 0 - 100. For pain intensity, higher scores indicate greater pain intensity. Data table measures show change over time with negative numbers indicating improvement (decreases) and positive numbers indicating increases in pain intensity. (NCT02116621)
Timeframe: baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care-1.92-1.46-1.76
Trialist Intervention-1.60-2.86-3.00

Longitudinal Change From Baseline up to 52 Weeks Follow-up in Pain-related Interference on the Patient-Reported Outcomes Measurement Information System (PROMIS) Scale

Pain-related Interference measured with Patient-Reported Outcomes Measurement Information System (PROMIS) scale 8-item short form at baseline, 13 weeks, 26 weeks, and 52 weeks which measures self-reported consequences of pain on relevant aspects of one's life. The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Pain interference scores range from 0 - 100. For pain interference, higher scores indicate greater pain interference. Data table measures show change over time with negative numbers indicating improvement (decreases) and positive numbers indicating increases in pain interference. (NCT02116621)
Timeframe: baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care-1.91-1.85-2.83
Trialist Intervention-2.70-3.22-2.67

Longitudinal Change From Baseline up to 52 Weeks Follow-up in Patient-provider Relationship on the Trust in Physician Scale

Patient trust in physician measured with 11-item Trust in Physician Scale at baseline, 13 weeks, 26 weeks, and 52 weeks to assess the quality of the patient-clinician relationship. Trust in physician scores range from 0 - 100. Higher scores indicate greater patient trust in the clinician providing pain treatment. Data table measures show change over time with positive numbers indicating increases in trust and negative numbers indicating declines in trust. (NCT02116621)
Timeframe: baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care-4.25-4.84-5.53
Trialist Intervention-2.49-2.30-4.00

Longitudinal Change From Baseline up to 52 Weeks Follow-up on the Pain Treatment Satisfaction Scale (PTSS) -Satisfaction With Medical Care

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline, 13 weeks, 26 weeks, 52 weeks, creating three subscales. Satisfaction with medical care is a subscale that includes 5 questions assessing medical care for pain. Satisfaction with medical care scores range from 0 - 100. Higher scores indicate greater patient satisfaction with medical care. Data table measures show change over time with positive numbers indicating increases in satisfaction with medical care and negative numbers indicating declines in patient satisfaction. (NCT02116621)
Timeframe: Baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care-6.15-5.57-5.51
Trialist Intervention-4.00-2.26-4.52

Longitudinal Change From Baseline up to 52 Weeks Follow-up on the Pain Treatment Satisfaction Scale (PTSS) -Satisfaction With Pain Information

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline, 13 weeks, 26 weeks, and 52 weeks, creating three subscales. Satisfaction with pain information is a subscale that includes 5 questions assessing information about pain and its treatment. Satisfaction with pain information range from 0-100. Higher scores indicate greater patient satisfaction with information received about pain and treatment for pain. Data table measures show change over time with positive numbers indicating increases in satisfaction with pain information and negative numbers indicating declines in patient satisfaction. (NCT02116621)
Timeframe: Baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care-3.363.994.89
Trialist Intervention4.4111.289.02

Longitudinal Change From Baseline up to 52 Weeks Follow-up on the Pain Treatment Satisfaction Scale (PTSS) -Satisfaction With Pain Medication

The Pain Treatment Satisfaction Scale consists of 18 items assessing patient satisfaction at baseline, 13 weeks, 26 weeks, 52 weeks, creating three subscales. Satisfaction with current pain medication is a subscale that includes 8 questions assessing current pain medications. Satisfaction with pain medication scores range from 0-100. Higher scores indicate greater patient satisfaction with current pain medications. Data table measures show change over time with positive numbers indicating increases in satisfaction with pain medications and negative numbers indicating declines in satisfaction with pain medications. (NCT02116621)
Timeframe: Baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care-0.341.39-0.34
Trialist Intervention1.46-0.180.77

Longitudinal Change From Baseline up to 52 Weeks Follow-up on the Patient-Reported Outcomes Measurement Information System (PROMIS) MENTAL Global Health Scale

Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale at baseline, 13 weeks, 26 weeks, and 52 weeks, representing physical and mental health components. Global mental health measures mental health, quality of life, satisfaction with social activities and emotional problems. The final mental health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Global mental health scores range from 0 - 100, and higher scores indicate better mental health. Data table measures show change over time with positive numbers indicating improvement in global mental health and negative numbers indicating declines in global mental health. (NCT02116621)
Timeframe: baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care0.30-0.72-0.39
Trialist Intervention-0.350.210.36

Longitudinal Change From Baseline up to 52 Weeks Follow-up on the Patient-Reported Outcomes Measurement Information System (PROMIS) PHYSICAL Global Health Scale

Global health measured with 10 item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale at baseline, 13 weeks, 26 weeks, 52 weeks, representing physical and mental health components. Global physical health measures overall physical health, physical function, pain and fatigue. The final physical health score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation of 10. Physical global health scores range from 0 - 100, and higher scores indicate better physical health. Data table measures show change over time with positive numbers indicating improvement in global physical health and negative numbers indicating declines in global physical health. (NCT02116621)
Timeframe: baseline, 13 weeks, 26 weeks, 52 weeks

,
Interventionunits on a scale (Least Squares Mean)
Change from baseline to 13 weeksChange from baseline to 26 weeksChange from baseline to 52 weeks
Control-Usual Care0.440.300.42
Trialist Intervention0.730.130.16

Brief Pain Inventory Interference Scale

Measure of pain-related functional interference (range 0-10; higher score is worse) (NCT01583985)
Timeframe: 3 months, 6 months, 9 months, and 12 months

,
Interventionunits on a scale (Mean)
3 months6 months9 months12 months
Non-opioid3.73.63.33.3
Opioid3.73.43.63.4

Brief Pain Inventory Severity Scale

Measure of pain intensity (range 0-10; higher score is worse) (NCT01583985)
Timeframe: 3 months, 6 months, 9 months, and 12 months

,
Interventionunits on a scale (Mean)
3 months6 months9 months12 months
Non-opioid4.04.13.63.5
Opioid4.34.14.24.0

Medication-related Symptom Checklist

Checklist of bothersome medication-related symptoms (0-19, higher number = more symptoms) (NCT01583985)
Timeframe: 3 months, 6 months, 9 months, and 12 months

,
Interventionsymptoms (Mean)
3 months6 months9 months12 months
Non-opioid1.31.30.90.9
Opioid2.32.11.91.8

Development of Chronic Opioid Use

Feasibility of collecting data on the percentage of patients who develop chronic opioid use. This is measured as the number of patients who received an opioid prescription per the Arkansas prescription drug monitoring database during the 90-150 day period post operatively. (NCT03986866)
Timeframe: 90-150 days

InterventionParticipants (Count of Participants)
No Video12
Video5

Knowledge of Post Operative Opioids

Knowledge of Post operative Opioids after surgery via 7 day post operative phone call. Knowledge is measured on a scale of 1 to 10 with 10 being complete knowledge and 1 being no knowledge. (NCT03986866)
Timeframe: 7 days

Interventionunits on a scale (Mean)
No Video8.32
Video9.36

Number of Patients Who Discontinued Opioids by 3 Months

Post-operative pain control as determined by opioid utilization at three months. This is the number of patients that have discontinued opioids at the 3 month mark. (NCT03986866)
Timeframe: Up to 3 months

InterventionParticipants (Count of Participants)
No Video47
Video38

Number of Total Days to Opioid Cessation

Feasibility of collecting data on the number of days until opioid cessation (NCT03986866)
Timeframe: Up to 3 months

Interventiondays (Mean)
No Video13.9
Video13.9

Percentage of Participants With Investigator's Global Assessment on Investigational Product

"Global assessment on investigational product was done by investigator on how well the investigational product controlled chronic (lasting a long time) low back pain. Assessment was done by categories 'Very bad (-2)' 'Bad (-1)' 'Not changed (0) 'Good (1)' and 'Very good (2)'. Assessment better than Good was considered as pain improvement success. Percentage of participants with pain improvement success is reported here." (NCT01112267)
Timeframe: Day 29

InterventionPercentage of participants (Number)
Tramadol HCl/Acetaminophen81.25
Placebo69.88

Percentage of Participants With Participants' Global Assessment on Investigational Product

"Global assessment on investigational product was done by participants on how well the investigational product controlled chronic (lasting a long time) low back pain. Assessment was done by categories 'Very bad (-2)' 'Bad (-1)' 'Not changed (0) 'Good (1)' and 'Very good (2)'. Assessment better than Good was considered as pain improvement success. Percentage of participants with pain improvement success is reported here." (NCT01112267)
Timeframe: Day 29

InterventionPercentage of participants (Number)
Tramadol HCl/Acetaminophen76.25
Placebo72.29

Percentage of Participants With Reduction in Pain Intensity

The percentage of participants with extent of reduction in pain intensity greater than or equal to 30 percent was reported. Pain intensity change rate was calculated by Visual Analog Scale (VAS) score at baseline minus VAS score at Day 29 divided by VAS score at Baseline. VAS is a 10 centimeter (cm) scale. Intensity of pain range: 0 cm=no pain to 10 cm=worst possible pain. (NCT01112267)
Timeframe: Baseline up to Day 29

InterventionPercentage of Participants (Number)
Tramadol HCl/Acetaminophen57.65
Placebo41.11

Change From Baseline in Oswestry Disability Index (ODI) Korean Version Score at Day 29

The ODI Korean version was used to assess the participant's functionality. The ODI is a low back pain-specific, validated instrument that consists of questions related to limitations in performing specific activities of daily living and 1 question related to pain intensity. The ODI is a self-administered questionnaire consists of 10 sections. Each section consists of 6 statements ranked from 0 to 5 (0=good to 5=worse). Total score is the sum of score obtained in each section and ranges from 0 to 50. A higher score represents greater disability. (NCT01112267)
Timeframe: Baseline and Day 29

,
InterventionUnit on a scale (Mean)
BaselineChange at Day 29 (n=87,83)
Placebo38.1267.178
Tramadol HCl/Acetaminophen39.62611.216

Change From Baseline in Pain Intensity at Day 29

Change in pain intensity experienced by participants over the last 48 hours was measured on Day 29 against Baseline with VAS. VAS is a 10 cm scale. Intensity of pain range: 0 cm=no pain to 10 cm=worst possible pain. (NCT01112267)
Timeframe: Baseline and Day 29

,
InterventionUnit on a scale (Mean)
BaselineChange at Day 29
Placebo6.0001.549
Tramadol HCl/Acetaminophen6.3342.299

Change From Baseline in Short Form (SF)-36 Score at Day 29

"The quality of life of participants was evaluated by SF-36 Korean version questionnaire. It is composed of 8 domains: physical and social functioning, physical and emotional role limitations, bodily pain, general health, vitality, mental health. Participants answered to the questionnaire of 36 questions; and physical, social, and psychological health status were assessed. It ranges 0 to 100, and higher score indicates better quality of life, But in Reported (Rptd.) Health Transition domain higher score indicates worse quality of life." (NCT01112267)
Timeframe: Baseline and Day 29

,
InterventionUnit on a scale (Mean)
Baseline: Physical functioningChange at Day 29: Physical functioning (n=83,87)Baseline: Role physicalChange at Day 29: Role Physical (n=83,87)Baseline: Bodily painChange at Day 29: Bodily pain (n=83,87)Baseline: General healthChange at Day 29: General health (n=83,87)Baseline: VitalityChange at Day 29: Vitality (n=83,87)Baseline: Social functioningChange at Day 29: Social functioning (n=83,87)Baseline: Role emotionalChange at Day 29: Role emotional (n=83,87)Baseline: Mental HealthChange at Day 29: Mental Health (n=83,87)Baseline: Rptd. health transitionChange at Day 29: Rptd. health transition(n=83,87)
Placebo47.946.6749.518.6935.9917.6948.112.7742.715.8264.586.6161.577.4760.5618.3963.61-6.90
Tramadol HCl/Acetaminophen46.719.8244.9316.0434.6619.3943.567.3638.8211.1464.2611.7561.768.1361.0620.4865.00-18.07

Percentage of Participants With Pain Relief

Pain relief was measured in 6 stages to assess the participant's pain relief. Extent of pain relief was measured on a scale ranging from 4 to -1, where 4=complete disappearance, 3=fair relief, 2=moderate relief, 1=slight relief, 0=no change and -1=pain worsening. Relief more than 'slight relief (1)' was considered as pain relief success. (NCT01112267)
Timeframe: Day 8, Day 15 and Day 29

,
InterventionPercentage of participants (Number)
Day 8: Slight relief (n=82,88)Day 15: Slight relief (n=85,89)Day 29, Slight relief (85,89)
Placebo53.4165.1777.53
Tramadol HCl/Acetaminophen70.7382.3581.18

ASES

American Shoulder and Elbow Surgeons (ASES) Shoulder Score for pain and function. Range 0-100. Low score = worse shoulder condition. Function, disability, and pain subscores (all ranges 0-50), and are summed for total ASES score. (NCT03540030)
Timeframe: 2 Weeks

Interventionunits on a scale (Median)
Observational54.3
Non-Opioid Intervention54.2

Morphine Use

Morphine milli-equivalents In-hospital post-operative. Continuous scale of MME, no defined better/worse. Measured as number and dose of medications taken. For example, if the patient received an opioid, the drug and dose was recorded and converted to MME. A time frame of when to assess opioid use in-hospital post-operative was not used but was a continuous monitor for rescue opioid from in-hospital post-operative through discharge. (NCT03540030)
Timeframe: In-hospital Stay

InterventionMorphine milli-equivalents (Median)
Observational45.0
Non-Opioid Intervention19.0

Post Op Pain

Pain at patient discharge or 24-hours, whichever comes first - measured on a 0 (no pain) -10 (worst possible pain) numeric rating scale (NRS). A score of 0(no pain) is preferable to 10(worst possible pain) (NCT03540030)
Timeframe: 24 hours

Interventionscore on a scale (Median)
Observational3.0
Non-Opioid Intervention2.0

Simple Shoulder Test

Simple Shoulder Test (SST) activity score. Range 0-12. 0 = worse activity score. (NCT03540030)
Timeframe: 2 Months

Interventionscore on a scale (Median)
Observational6
Non-Opioid Intervention6

Simple Shoulder Test

Simple Shoulder Test (SST) activity score. Range 0-12. 0 = worse activity score. (NCT03540030)
Timeframe: 2 Weeks

Interventionscore on a scale (Median)
Observational2.0
Non-Opioid Intervention2.0

Additional Post Op Pain

post-operative pain: measured on a 0 (no pain) -10 (worst) numeric rating scale (NRS) at 6hrs, 12hrs, 2 weeks, and 2 months. A score of 0(no pain) is preferable to 10(worst possible pain) (NCT03540030)
Timeframe: 6hrs, 12hrs, 2weeks, 2 months

,
Interventionscore on a scale (Median)
6 Hrs12 hrs2 weeks2 months
Non-Opioid Intervention0.000.820
Observational241.30.7

Constipation

rate of constipation (NCT03540030)
Timeframe: 2 Months

,
InterventionParticipants (Count of Participants)
YesNoUnknown
Non-Opioid Intervention4274
Observational7212

Constipation

rate of constipation (NCT03540030)
Timeframe: 2 Weeks

,
InterventionParticipants (Count of Participants)
YesNoUnknown
Non-Opioid Intervention13220
Observational1992

Falls

rate of falls (NCT03540030)
Timeframe: 2 Months

,
InterventionParticipants (Count of Participants)
YesNoUnknown
Non-Opioid Intervention4274
Observational4242

Falls

rate of falls (NCT03540030)
Timeframe: 2 Weeks

,
InterventionParticipants (Count of Participants)
YesNoUnknown
Non-Opioid Intervention5300
Observational1272

Nausea

rate of nausea (NCT03540030)
Timeframe: 2 Months

,
InterventionParticipants (Count of Participants)
YesNoUnknown
Non-Opioid Intervention1300
Observational0282

Nausea

rate of nausea (NCT03540030)
Timeframe: 2 Weeks

,
InterventionParticipants (Count of Participants)
YesNoUnknown
Non-Opioid Intervention1340
Observational5232

Pain Satisfaction

Satisfaction with overall pain using Numeric Pain Rating (NRS) scale. yes, no. No being better than yes. (NCT03540030)
Timeframe: 2 Months

,
InterventionParticipants (Count of Participants)
YesNoUnknown
Non-Opioid Intervention2924
Observational2352

Pain Satisfaction

Satisfaction with overall pain using Numeric Pain Rating (NRS) scale. yes, no. No being better than yes. (NCT03540030)
Timeframe: 2 Weeks

,
InterventionParticipants (Count of Participants)
YesNoUnknown
Non-Opioid Intervention3410
Observational2712

Veterans RAND 12 Item Health Survey (VR-12©) Physical Health Subscore, and Mental Health Subscore

quality of life using VR-12 subscores. Physical Health (PCS) subscore and Mental Health (MCS) subscore, not summed. Range reported in weighted units. Physical Health subscore: 1 point increase in PCS is associated with 6% lower total health care expenditures, 5% lower pharmacy expenditures, 9% lower rate of hospital inpatient visits, 4% lower rate of medical provider visits, 5% lower rate of hospital outpatient visits. Mental Health sub score a 1 point increase in MCS is associated with 7% lower total health care expenditures, 4% lower pharmacy expenditures, 15% lower rate of hospital inpatient visits, and 4% lower rate of medical provider visits. Both PCS/MCS are score 0-100 with 100 indicating the highest level of health. (NCT03540030)
Timeframe: 2 Months

,
Interventionscore on a scale (Median)
PCSMCS
Non-Opioid Intervention40.360.8
Observational38.458.7

Veterans RAND 12 Item Health Survey (VR-12©) Physical Health Subscore, and Mental Health Subscore

quality of life using VR-12 subscores. Physical Health (PCS) subscore and Mental Health (MCS) subscore, not summed. Range reported in weighted units. Physical Health subscore: 1 point increase in PCS is associated with 6% lower total health care expenditures, 5% lower pharmacy expenditures, 9% lower rate of hospital inpatient visits, 4% lower rate of medical provider visits, 5% lower rate of hospital outpatient visits. Mental Health sub score a 1 point increase in MCS is associated with 7% lower total health care expenditures, 4% lower pharmacy expenditures, 15% lower rate of hospital inpatient visits, and 4% lower rate of medical provider visits. Both PCS/MCS are score 0-100 with 100 indicating the highest level of health. (NCT03540030)
Timeframe: 2 Weeks

,
Interventionscore on a scale (Median)
PCSMCS
Non-Opioid Intervention35.059.1
Observational36.756.3

Change in Back Pain

The Roland-Morris Disability Questionnaire is designed to assess self-rated physical disability caused by low back pain. The patient is asked to agree or disagree with 24 different statements related to their back pain. The end score is the sum of the agreed statements. The score ranges from 0 (no disability) to 24 (maximum disability). (NCT02146482)
Timeframe: Baseline (Week 1) and Follow-Up (Week 18)

,
Interventionunits on a scale (Median)
BaselineFollow Up
Control64
Sit-stand Computer Workstation8.51.5

Reviews

31 reviews available for acetaminophen and Chronic Pain

ArticleYear
The Effects of Pain and Analgesic Medications on Blood Pressure.
    Current hypertension reports, 2022, Volume: 24, Issue:10

    Topics: Acetaminophen; Adrenergic Agents; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Ster

2022
Strategies of analgesic treatment after cesarean delivery. Current state and new alternatives.
    Revista espanola de anestesiologia y reanimacion, 2020, Volume: 67, Issue:3

    Topics: Acetaminophen; Analgesia, Obstetrical; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia, Epi

2020
Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain.
    BioMed research international, 2020, Volume: 2020

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Anticonvulsants; Antidepressiv

2020
Paracetamol for low back pain: the state of the research field.
    Expert review of clinical pharmacology, 2020, Volume: 13, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Low Back Pain; Randomized

2020
The pharmacological management of chronic lower back pain.
    Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:1

    Topics: Acetaminophen; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; C

2021
Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents.
    The Cochrane database of systematic reviews, 2017, 08-02, Volume: 8

    Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Child; Chronic Pain; Humans

2017
Impact of medication on protein and amino acid metabolism in the elderly: the sulfur amino acid and paracetamol case.
    Nutrition research reviews, 2018, Volume: 31, Issue:2

    Topics: Acetaminophen; Aged; Amino Acids, Sulfur; Animals; Chronic Pain; Cysteine; Dietary Proteins; Frail E

2018
Novel Pharmacological Nonopioid Therapies in Chronic Pain.
    Current pain and headache reports, 2018, Apr-03, Volume: 22, Issue:4

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Chronic Pain; Humans; Opioid-R

2018
Understanding osteoporotic pain and its pharmacological treatment.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2018, Volume: 29, Issue:7

    Topics: Acetaminophen; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservatio

2018
Long-term adverse effects of paracetamol - a review.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:10

    Topics: Acetaminophen; Acute Kidney Injury; Analgesics, Non-Narcotic; Asthma; Cardiovascular Diseases; Chron

2018
[Errors and Solutions During Medical Therapy for Chronic Pain].
    Deutsche medizinische Wochenschrift (1946), 2018, Volume: 143, Issue:19

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal

2018
Opioid Adjuncts: Optimizing Opioid Therapy With Nonopioid Medications.
    Clinical obstetrics and gynecology, 2019, Volume: 62, Issue:1

    Topics: Acetaminophen; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Anti

2019
Revisiting established medicines: An overview of systematic reviews about ibuprofen and paracetamol for treating pain in children.
    European journal of pain (London, England), 2019, Volume: 23, Issue:6

    Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, N

2019
Evidence-Based Recommendations on the Pharmacological Management of Osteoarthritis and Chronic Low Back Pain: An Asian Consensus
    Asian journal of anesthesiology, 2019, 06-01, Volume: 57, Issue:2

    Topics: Acetaminophen; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidep

2019
Tramadol and acetaminophen combination for chronic non-cancer pain.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:16

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Chronic Pain; Drug Combination

2013
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
    Drugs & aging, 2014, Volume: 31, Issue:2

    Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam

2014
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
    Drugs & aging, 2014, Volume: 31, Issue:2

    Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam

2014
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
    Drugs & aging, 2014, Volume: 31, Issue:2

    Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam

2014
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
    Drugs & aging, 2014, Volume: 31, Issue:2

    Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam

2014
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
    Drugs & aging, 2014, Volume: 31, Issue:2

    Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam

2014
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
    Drugs & aging, 2014, Volume: 31, Issue:2

    Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam

2014
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
    Drugs & aging, 2014, Volume: 31, Issue:2

    Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam

2014
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
    Drugs & aging, 2014, Volume: 31, Issue:2

    Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam

2014
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
    Drugs & aging, 2014, Volume: 31, Issue:2

    Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam

2014
An overview of pain management: the clinical efficacy and value of treatment.
    The American journal of managed care, 2013, Volume: 19, Issue:14 Suppl

    Topics: Acetaminophen; Acute Disease; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chronic P

2013
How to set boundaries with chronic pain patients.
    The Journal of family practice, 2014, Volume: 63, Issue:3 Suppl

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Pain; Decision Support Techniqu

2014
Understanding the cancer pain experience.
    Current pain and headache reports, 2014, Volume: 18, Issue:8

    Topics: Acetaminophen; Analgesics; Chronic Pain; Critical Pathways; Fentanyl; Humans; Ketamine; Neoplasms; O

2014
Management of opioid painkiller dependence in primary care: ongoing recovery with buprenorphine/naloxone.
    BMJ case reports, 2014, Nov-28, Volume: 2014

    Topics: Acetaminophen; Analgesics, Opioid; Buprenorphine; Chronic Pain; Codeine; Counseling; Fatigue Syndrom

2014
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions.
    European journal of pain (London, England), 2015, Volume: 19, Issue:9

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Humans; Ibuprofen

2015
Pain management in the elderly.
    The Medical clinics of North America, 2015, Volume: 99, Issue:2

    Topics: Acetaminophen; Administration, Topical; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Ant

2015
Acetaminophen for Chronic Pain: A Systematic Review on Efficacy.
    Basic & clinical pharmacology & toxicology, 2016, Volume: 118, Issue:3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Chronic Disease; Chronic Pain; Databases, Factual; Humans;

2016
Ongoing Pharmacological Management of Chronic Pain in Pregnancy.
    Drugs, 2016, Volume: 76, Issue:9

    Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chr

2016
Advanced Concepts and Controversies in Emergency Department Pain Management.
    Anesthesiology clinics, 2016, Volume: 34, Issue:2

    Topics: Acetaminophen; Acute Pain; Analgesia, Patient-Controlled; Analgesics, Opioid; Anti-Inflammatory Agen

2016
[Analgesic drugs during pregnancy].
    Schmerz (Berlin, Germany), 2016, Volume: 30, Issue:6

    Topics: Abnormalities, Drug-Induced; Acetaminophen; Acute Pain; Analgesics; Analgesics, Opioid; Anticonvulsa

2016
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults.
    The Cochrane database of systematic reviews, 2016, 12-27, Volume: 12

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Pain; Codeine; Humans; N

2016
Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline.
    Annals of internal medicine, 2017, Apr-04, Volume: 166, Issue:7

    Topics: Acetaminophen; Acute Pain; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Analgesics, Opioid; An

2017
Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline.
    Annals of internal medicine, 2017, Apr-04, Volume: 166, Issue:7

    Topics: Acetaminophen; Acute Pain; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Analgesics, Opioid; An

2017
Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline.
    Annals of internal medicine, 2017, Apr-04, Volume: 166, Issue:7

    Topics: Acetaminophen; Acute Pain; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Analgesics, Opioid; An

2017
Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline.
    Annals of internal medicine, 2017, Apr-04, Volume: 166, Issue:7

    Topics: Acetaminophen; Acute Pain; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Analgesics, Opioid; An

2017
[Chronic pain following spine surgery].
    Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology, 2012, Volume: 24, Issue:1

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal

2012
[Skin ulcer pain].
    Minerva medica, 2012, Volume: 103, Issue:6

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Chroni

2012
Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain.
    Clinical drug investigation, 2012, Volume: 32 Suppl 1

    Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chronic Pain

2012

Trials

21 trials available for acetaminophen and Chronic Pain

ArticleYear
Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee.
    BMJ open, 2023, 02-10, Volume: 13, Issue:2

    Topics: Acetaminophen; Activities of Daily Living; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal

2023
Association of
    Radiology and oncology, 2023, 03-01, Volume: 57, Issue:1

    Topics: Acetaminophen; Acute Pain; Breast Neoplasms; Chronic Pain; Female; Humans; MicroRNAs; Neuralgia; Rec

2023
Evaluation of the Effect of New Multimodal Analgesia Regimen for Cardiac Surgery: A Prospective, Randomized Controlled, Single-Center Clinical Study.
    Drug design, development and therapy, 2023, Volume: 17

    Topics: Acetaminophen; Analgesia; Cardiac Surgical Procedures; Chronic Pain; Dexmedetomidine; Gabapentin; Hu

2023
Effect of Mobile Device-Assisted N-of-1 Trial Participation on Analgesic Prescribing for Chronic Pain: Randomized Controlled Trial.
    Journal of general internal medicine, 2020, Volume: 35, Issue:1

    Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chronic Pain

2020
A randomized-controlled pilot trial of an online compassionate mind training intervention to help people with chronic pain avoid analgesic misuse.
    Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2020, Volume: 34, Issue:7

    Topics: Acetaminophen; Adult; Analgesics; Analgesics, Opioid; Arthritis, Rheumatoid; Aspirin; Back Pain; Chr

2020
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    JAMA, 2018, 03-06, Volume: 319, Issue:9

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-In

2018
Effect of effervescent paracetamol on blood pressure: a crossover randomized clinical trial.
    Journal of hypertension, 2018, Volume: 36, Issue:8

    Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Antihypertensive Agents; Blood Pressure; Blood Pressu

2018
Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM).
    Drugs & aging, 2018, Volume: 35, Issue:6

    Topics: Acetaminophen; Administration, Cutaneous; Aged, 80 and over; Analgesics; Buprenorphine; Chronic Pain

2018
Acetaminophen reduces acute and persistent incisional pain after hysterectomy.
    Annali italiani di chirurgia, 2018, Volume: 89

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Chronic Pain; Female; Humans; Hysterectomy; Pai

2018
A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
    Clinical therapeutics, 2013, Volume: 35, Issue:11

    Topics: Acetaminophen; Adult; Aged; Analgesics; Chronic Pain; Delayed-Action Preparations; Double-Blind Meth

2013
Do analgesics improve functioning in patients with chronic low back pain? An explorative triple-blinded RCT.
    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2014, Volume: 23, Issue:4

    Topics: Acetaminophen; Adult; Analgesics; Chronic Pain; Disability Evaluation; Double-Blind Method; Drug Adm

2014
Endogenous pain modulation in response to exercise in patients with rheumatoid arthritis, patients with chronic fatigue syndrome and comorbid fibromyalgia, and healthy controls: a double-blind randomized controlled trial.
    Pain practice : the official journal of World Institute of Pain, 2015, Volume: 15, Issue:2

    Topics: Acetaminophen; Adult; Aged; Analgesia; Analgesics, Non-Narcotic; Arthritis, Rheumatoid; Chronic Pain

2015
Intermittent epidural vs continuous wound infusion of ropivacaine for acute and chronic pain control after hysterectomy or myomectomy: a randomized controlled trial.
    Pain medicine (Malden, Mass.), 2014, Volume: 15, Issue:9

    Topics: Acetaminophen; Acute Pain; Adult; Amides; Analgesia, Epidural; Analgesics; Anesthetics, Local; Chron

2014
Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain.
    Postgraduate medicine, 2015, Volume: 127, Issue:1

    Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Pain; Double-Blind

2015
Analgesia evaluation of 2 NSAID drugs as adjuvant in management of chronic temporomandibular disorders.
    TheScientificWorldJournal, 2015, Volume: 2015

    Topics: Acetaminophen; Adult; Aged; Analgesia; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Carisoprod

2015
Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
    Clinical therapeutics, 2015, Jun-01, Volume: 37, Issue:6

    Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Pain; Delayed-Acti

2015
Preoperative dexamethasone reduces acute but not sustained pain after lumbar disk surgery: a randomized, blinded, placebo-controlled trial.
    Pain, 2015, Volume: 156, Issue:12

    Topics: Acetaminophen; Acute Pain; Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Anti-Inflammato

2015
Balneotherapy for chronic low back pain: a randomized, controlled study.
    Rheumatology international, 2012, Volume: 32, Issue:10

    Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Analysis of Variance; Balneology; Chi-Square Distribu

2012
[Ibuprofen/paracetamol combination therapy is more effective than monotherapy in knee pain, but increases bleeding risk].
    Praxis, 2012, Mar-14, Volume: 101, Issue:6

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Pai

2012
Effect of adding cervical facet joint injections in a multimodal treatment program for long-standing cervical myofascial pain syndrome with referral pain patterns of cervical facet joint syndrome.
    Journal of anesthesia, 2012, Volume: 26, Issue:5

    Topics: Acetaminophen; Anesthetics, General; Chronic Pain; Clonidine; Codeine; Combined Modality Therapy; Do

2012
Perioperative pregabalin for acute and chronic pain after abdominal hysterectomy or myomectomy: a randomised controlled trial.
    European journal of anaesthesiology, 2012, Volume: 29, Issue:11

    Topics: Acetaminophen; Acute Pain; Adult; Analgesics; Chronic Pain; Codeine; Double-Blind Method; Drug Combi

2012

Other Studies

40 other studies available for acetaminophen and Chronic Pain

ArticleYear
Practice guidelines for the treatment of acute migraine and chronic knee osteoarthritis with paracetamol: an expert appraisal on evolution over time between scientific societies.
    Current medical research and opinion, 2022, Volume: 38, Issue:9

    Topics: Acetaminophen; Chronic Pain; Humans; Migraine Disorders; Osteoarthritis, Hip; Osteoarthritis, Knee;

2022
Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.
    Journal of osteopathic medicine, 2023, 01-01, Volume: 123, Issue:1

    Topics: Acetaminophen; Analgesics, Opioid; Animals; Breakthrough Pain; Buprenorphine; Cattle; Chronic Pain;

2023
Analgesic utilization in people with knee osteoarthritis: A population-based study using primary care data.
    Pain practice : the official journal of World Institute of Pain, 2023, Volume: 23, Issue:5

    Topics: Acetaminophen; Adult; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chron

2023
Perceptions of West Virginia Teens and Adults Regarding the Risks of Over-the-Counter Pain Medications.
    Journal of pain & palliative care pharmacotherapy, 2023, Volume: 37, Issue:2

    Topics: Acetaminophen; Adolescent; Adult; Chronic Pain; Humans; Nonprescription Drugs; Surveys and Questionn

2023
Presence and grade of undertreatment of pain in children with cerebral palsy.
    Scandinavian journal of pain, 2023, 07-26, Volume: 23, Issue:3

    Topics: Acetaminophen; Adaptation, Psychological; Adolescent; Adult; Cerebral Palsy; Child; Child, Preschool

2023
A new OPIATE (Optimizing Positive Ibuprofen and Acetaminophen Treatment Expectations) model: A brief comment on "Concurrent and lagged associations of prescription opioid use with pain and negative affect in the daily lives of chronic pain patients" (Carp
    Journal of consulting and clinical psychology, 2019, Volume: 87, Issue:10

    Topics: Acetaminophen; Affect; Analgesics, Opioid; Chronic Pain; Humans; Ibuprofen; Motivation; Opiate Alkal

2019
Efficacy and safety of modified-release paracetamol for acute and chronic pain: a systematic review protocol.
    BMJ open, 2019, Oct-14, Volume: 9, Issue:10

    Topics: Acetaminophen; Acute Disease; Administration, Oral; Adult; Australia; Child; Child, Preschool; Chron

2019
Attitudes toward and Barriers to Acetaminophen Use in the Chronic Pain Population: A Cross-Sectional Study.
    Journal of pain & palliative care pharmacotherapy, 2020, Volume: 34, Issue:3

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Attitude; Chronic Pain; Cross-Sectional Studies; Fema

2020
Physician-Delivered Pain Neuroscience Education for Opioid Tapering: A Case Report.
    International journal of environmental research and public health, 2020, 05-11, Volume: 17, Issue:9

    Topics: Acetaminophen; Aged; Analgesics, Opioid; Chronic Pain; Female; Fentanyl; Humans; Hydrocodone; Low Ba

2020
Influence of acetaminophen on renal function: a longitudinal descriptive study using a real-world database.
    International urology and nephrology, 2021, Volume: 53, Issue:1

    Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster

2021
A retrospective analysis of the effects of different analgesics on the pain of patients with traumatic thoracolumbar fractures in the peri-treatment period.
    Journal of orthopaedic surgery and research, 2021, Apr-17, Volume: 16, Issue:1

    Topics: Acetaminophen; Acute Pain; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Chronic Pain; Cod

2021
Oral Multimodal Analgesia for Total Joint Arthroplasty.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:9S

    Topics: Acetaminophen; Analgesia; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Arthroplasty, Re

2017
Ginger rhizome enhances the anti-inflammatory and anti-nociceptive effects of paracetamol in an experimental mouse model of fibromyalgia.
    Inflammopharmacology, 2018, Volume: 26, Issue:4

    Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Chronic Pain; Disease Models, Animal; Drug Synergi

2018
Opioids for Acute Pain: Proceed with Caution.
    American family physician, 2018, Feb-01, Volume: 97, Issue:3

    Topics: Acetaminophen; Acute Pain; Adult; Analgesics, Opioid; Chronic Pain; Drug Combinations; Female; Fract

2018
[Side Effects of Acetaminophen and their Management].
    Masui. The Japanese journal of anesthesiology, 2016, Volume: 65, Issue:7

    Topics: Acetaminophen; Aspirin; Chronic Pain; Cyclooxygenase 1; Fever; Humans; Pain Management; Reye Syndrom

2016
The glycation products before and after therapy for acute and chronic pain.
    Physiological research, 2018, 12-31, Volume: 67, Issue:Suppl 4

    Topics: Acetaminophen; Acute Pain; Adult; Analgesics, Opioid; Biomarkers; Chronic Pain; Female; Glycation En

2018
Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.
    Clinical journal of the American Society of Nephrology : CJASN, 2019, 06-07, Volume: 14, Issue:6

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Analgesics, Opioid; Carbamazepine; Chronic Pain

2019
Ethical quandaries in caring for primary-care patients with chronic pain.
    Families, systems & health : the journal of collaborative family healthcare, 2013, Volume: 31, Issue:1

    Topics: Acetaminophen; Back Pain; Behavioral Medicine; Chronic Pain; Clinical Competence; Codes of Ethics; D

2013
The management of HIV- and AIDS-related pain in a primary health clinic in Tshwane, South Africa.
    Pain management nursing : official journal of the American Society of Pain Management Nurses, 2013, Volume: 14, Issue:2

    Topics: Acetaminophen; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Analgesics, Non-Narcotic

2013
[Tramadol/acetaminophen combination tablets].
    Masui. The Japanese journal of anesthesiology, 2013, Volume: 62, Issue:7

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Pain; Drug Combinations; Humans

2013
Rational prescribing.
    Minnesota medicine, 2013, Volume: 96, Issue:3

    Topics: Acetaminophen; Analgesics, Opioid; Chronic Pain; Drug Combinations; Humans; Long-Term Care; Minnesot

2013
The therapeutic management of chronic pain in ambulatory care patients aged 65 and over in France: the S.AGES Cohort. Baseline data.
    The journal of nutrition, health & aging, 2013, Volume: 17, Issue:8

    Topics: Acetaminophen; Aged; Aged, 80 and over; Ambulatory Care; Analgesics; Back Pain; Chronic Pain; Dextro

2013
[Self-medication to treat pain in attacks of familial Mediterranean fever: aiming to find a new approach to pain management].
    Schmerz (Berlin, Germany), 2013, Volume: 27, Issue:6

    Topics: Acetaminophen; Adult; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chron

2013
How safe is acetaminophen in rheumatology?
    Joint bone spine, 2014, Volume: 81, Issue:1

    Topics: Acetaminophen; Cardiovascular Diseases; Chronic Pain; Humans; Musculoskeletal Pain; Osteoarthritis;

2014
Pregabalin reduces opioid consumption and improves outcome in chronic pain patients undergoing total knee arthroplasty.
    The Physician and sportsmedicine, 2014, Volume: 42, Issue:2

    Topics: Acetaminophen; Aged; Analgesics; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Celecoxib; Chr

2014
Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:5

    Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Blood Pressure; Chronic Pain; Confounding Factors, Ep

2015
Should acetaminophen be added to the list of anti-inflammatory agents that are associated with cardiovascular events?
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:5

    Topics: Acetaminophen; Blood Pressure; Chronic Pain; Female; Humans; Hypertension; Male; Myocardial Infarcti

2015
Sucrose-induced analgesia during early life modulates adulthood learning and memory formation.
    Physiology & behavior, 2015, Jun-01, Volume: 145

    Topics: Acetaminophen; Analgesics; Animals; Animals, Newborn; beta-Endorphin; Chronic Pain; Disease Models,

2015
Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids.
    BMC public health, 2015, May-02, Volume: 15

    Topics: Acetaminophen; Adult; Age Factors; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Aspirin;

2015
Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.
    Drug development and industrial pharmacy, 2016, Volume: 42, Issue:1

    Topics: Acetaminophen; Acute Pain; Administration, Intranasal; Analgesics, Opioid; Chronic Pain; Delayed-Act

2016
The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids.
    International journal of clinical practice, 2015, Volume: 69, Issue:11

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Austral

2015
Overall safety profile and effectiveness of tramadol hydrochloride/acetaminophen in patients with chronic noncancer pain in Japanese real-world practice.
    Current medical research and opinion, 2015, Volume: 31, Issue:11

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic

2015
Effect of Preoperative Inflammatory Status and Comorbidities on Pain Resolution and Persistent Postsurgical Pain after Inguinal Hernia Repair.
    Mediators of inflammation, 2016, Volume: 2016

    Topics: Acetaminophen; Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chronic Pai

2016
Chronic pain among community-dwelling elderly: a population-based clinical study.
    Scandinavian journal of primary health care, 2016, Volume: 34, Issue:2

    Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster

2016
Analgesic drugs and the gut - a reciprocal relationship.
    The journal of the Royal College of Physicians of Edinburgh, 2015, Volume: 45, Issue:4

    Topics: Acetaminophen; Administration, Oral; Amines; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agent

2015
A case of delayed onset pyroglutamic acidosis in the sub-acute setting.
    Internal medicine journal, 2016, Volume: 46, Issue:6

    Topics: Acetaminophen; Acidosis, Renal Tubular; Aged; Chronic Pain; Floxacillin; Humans; Male; Osteomyelitis

2016
Effect of Tramadol/Acetaminophen on Motivation in Patients with Chronic Low Back Pain.
    Pain research & management, 2016, Volume: 2016

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Apathy;

2016
Pain severity and pharmacologic pain management among community-living older adults: the MOBILIZE Boston study.
    Aging clinical and experimental research, 2017, Volume: 29, Issue:6

    Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Chronic Pain; Cohort Studies

2017
Surrogate decision making: a woman in fulminant liver failure after an acetaminophen overdose.
    Surgery, 2011, Volume: 150, Issue:5

    Topics: Acetaminophen; Advance Care Planning; Analgesics, Non-Narcotic; Chronic Pain; Critical Care; Decisio

2011
Analgesic use in a national community sample of German children and adolescents.
    European journal of pain (London, England), 2012, Volume: 16, Issue:6

    Topics: Acetaminophen; Acute Pain; Adolescent; Analgesics; Aspirin; Child; Child, Preschool; Chronic Pain; F

2012